V
9.25
0.25 (2.78%)
| Previous Close | 9.00 |
| Open | 9.07 |
| Volume | 44,816 |
| Avg. Volume (3M) | 240,023 |
| Market Cap | 995,670,016 |
| Price / Earnings (TTM) | 10.76 |
| Price / Earnings (Forward) | 15.17 |
| Price / Sales | 0.830 |
| Price / Book | 0.870 |
| 52 Weeks Range | |
| Earnings Date | 12 Dec 2023 - 22 Dec 2023 |
| Profit Margin | 3.97% |
| Operating Margin (TTM) | 16.59% |
| Diluted EPS (TTM) | 0.970 |
| Quarterly Revenue Growth (YOY) | 5.00% |
| Quarterly Earnings Growth (YOY) | -10.20% |
| Total Debt/Equity (MRQ) | 18.59% |
| Current Ratio (MRQ) | 3.20 |
| Operating Cash Flow (TTM) | 160.81 M |
| Levered Free Cash Flow (TTM) | 155.57 M |
| Return on Assets (TTM) | 2.16% |
| Return on Equity (TTM) | 8.93% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | Veradigm Inc. | Mixed | Bearish |
Stockmoo Score
1.8
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 1.83 |
|
Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 1.12% |
| % Held by Institutions | 23.22% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Mason Capital Management Llc | 30 Jun 2024 | 938,238 |
| Metlife Investment Management, Llc | 31 Dec 2023 | 59,347 |
| Front Row Advisors Llc | 30 Jun 2024 | 220 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 21 Nov 2024 | Announcement | Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden |
| 19 Nov 2024 | Announcement | Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration |
| 10 Oct 2024 | Announcement | Veradigm Advances Deeper Clinical Insights Through NLP-Enhanced EHR Data |
| 03 Oct 2024 | Announcement | Automated Medical Chart Retrieval Expands to 300,000+ U.S. Healthcare Providers via Veradigm eChart Courier |
| 26 Sep 2024 | Announcement | Veradigm Ranked Top Vendor by KLAS |
| 29 Aug 2024 | Announcement | Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |